Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/14672
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAkhtar, Mahwish-
dc.contributor.authorSultana, Najma-
dc.contributor.authorArayne, Mohammad Saeed-
dc.contributor.authorSiddiqi, Tanveer Ahmed-
dc.contributor.authorKhan, Ajmal-
dc.date.accessioned2022-12-06T03:31:01Z-
dc.date.available2022-12-06T03:31:01Z-
dc.date.issued2019-05-04-
dc.identifier.citationAkhtar, M., Sultana, N., Arayne, M. S., Siddiqi, T. A., & Khan, A. (2019). Moxifloxacin-Ester derivatives: Synthesis, characterization and pharmacological evaluation. Pakistan Journal of Pharmaceutical Sciences, 32(3 Special), 1301-1306.en_US
dc.identifier.issn1011-601X-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/14672-
dc.description.abstract: It is known that resistance of bacteria is one of the major issues in drug treatment. To cope this issue, it is required to synthesize new analogues which contest against mutated bacteria. This research study included synthesis of several derivatives of moxifloxacin by adding different phenol and alkyl halide at third position of carboxylic group with esterification reaction and the structures of synthesized derivatives were characterized by spectroscopic techniques i.e. 1H NMR, FT-IR and mass-spectrometry. In continuation, antimicrobial activities of the analogues were also evaluated against number of Gram-positive, Gram-negative bacteria and fungi. The experimental results of novel derivatives exhibit significant antibacterial and antifungal profile in which so many synthesized derivatives influenced a similar and enhanced activity against selected microbes that were S. typhi, P. mirabilis, P. aeruginosa, S. flexneri, B. subtilis as compared to the moxifloxacin. Moreover, few innovative derivatives were also produced better anti-fungal activity against F. solani and T. rubrum. Furthermore, the enzymatic activity of all analogues has been analyzed against urease and carbonic anhydrase and concluded that C2 was selected inhibitor of urease enzyme.en_US
dc.language.isoenen_US
dc.publisherKarachi: Faculty of Pharmacy & Pharmaceutical Sciences, Karachien_US
dc.subjectMoxifloxacinen_US
dc.subjectEster derivativesen_US
dc.subjectANOVAen_US
dc.subjectantifungal activityen_US
dc.subjectantibacterial activityen_US
dc.titleMoxifloxacin-Ester derivatives: Synthesis, characterization and pharmacological evaluationen_US
dc.typeArticleen_US
Appears in Collections:Issue 3 (Special)

Files in This Item:
File Description SizeFormat 
4-7208-SP.htm140 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.